Fundraising FoxAvlar BioVentures
Venture capitalMadingley · Series A–Growth
Find your way into Avlar BioVentures
What they invest in
from 1 of 1 portfolio companiesBiotech ×1Healthtech ×1Medical Devices ×1
Investments · 1 tracked
founders shown can be your intro path
Crescendo Biologics develops novel immune cell-enhancing therapeutics for immuno-oncology using its patent-protected Humabody VH platform, a fully human domain technology clinically validated in oncology and immunology.
BiotechHealthtechMedical Devices
Co-investorsAndera PartnersQuan CapitalSofinnova PartnersAstellas Venture Management LLCEMBL VenturesFuture Planet Capital+2 more
Frequently asked questions
- What stage does Avlar BioVentures invest at?
- Avlar BioVentures invests at the Series A, Series B, Series C, Growth stages.
- What sectors does Avlar BioVentures focus on?
- Avlar BioVentures focuses on Biotech, Healthtech, IoT, Medical Devices.
- Where is Avlar BioVentures located?
- Avlar BioVentures is headquartered in Madingley, GB.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Ambix is a healthcare-focused investment firm that provides funding, strategy, and hands-on support to companies developing medical tools and devices, biochemistry-based technologies, digital health applications, and other novel healthcare solutions. It invests across all stages and also builds companies itself.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
M Ventures is the corporate venture arm of Merck KGaA based in Darmstadt, Germany, operating from offices in Amsterdam, the US, and Israel. The firm invests globally across early-stage companies and spin-offs in areas aligned with Merck's core business, taking active roles in portfolio company development.